DE60037653D1 - Gelatine-freie schell dispergierende dosisformen - Google Patents

Gelatine-freie schell dispergierende dosisformen

Info

Publication number
DE60037653D1
DE60037653D1 DE60037653T DE60037653T DE60037653D1 DE 60037653 D1 DE60037653 D1 DE 60037653D1 DE 60037653 T DE60037653 T DE 60037653T DE 60037653 T DE60037653 T DE 60037653T DE 60037653 D1 DE60037653 D1 DE 60037653D1
Authority
DE
Germany
Prior art keywords
dosage forms
solid dosage
free
active ingredient
schell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60037653T
Other languages
English (en)
Other versions
DE60037653T2 (de
Inventor
Leon Paul Grother
Owen James Murray
Richard Green
Patrick Kearney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catalent Pharma Solutions Inc
Original Assignee
Catalent Pharma Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent Pharma Solutions Inc filed Critical Catalent Pharma Solutions Inc
Publication of DE60037653D1 publication Critical patent/DE60037653D1/de
Application granted granted Critical
Publication of DE60037653T2 publication Critical patent/DE60037653T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
DE60037653T 1999-01-27 2000-01-27 Gelatine-freie schell dispergierende dosisformen Expired - Lifetime DE60037653T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9901819.4A GB9901819D0 (en) 1999-01-27 1999-01-27 Pharmaceutical compositions
GB9901819 1999-01-27
PCT/US2000/001868 WO2000044351A1 (en) 1999-01-27 2000-01-27 Fast dispersing dosage forms free of gelatin

Publications (2)

Publication Number Publication Date
DE60037653D1 true DE60037653D1 (de) 2008-02-14
DE60037653T2 DE60037653T2 (de) 2008-10-30

Family

ID=10846608

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60037653T Expired - Lifetime DE60037653T2 (de) 1999-01-27 2000-01-27 Gelatine-freie schell dispergierende dosisformen

Country Status (25)

Country Link
EP (1) EP1154757B1 (de)
JP (1) JP4863336B2 (de)
KR (1) KR100852015B1 (de)
CN (1) CN1193740C (de)
AT (1) ATE382334T1 (de)
AU (1) AU768121B2 (de)
BG (1) BG65413B1 (de)
CA (1) CA2360647C (de)
CY (1) CY1107384T1 (de)
CZ (1) CZ301249B6 (de)
DE (1) DE60037653T2 (de)
DK (1) DK1154757T3 (de)
ES (1) ES2298129T3 (de)
GB (1) GB9901819D0 (de)
HK (1) HK1037536A1 (de)
HU (1) HU226557B1 (de)
IL (2) IL144412A0 (de)
IS (1) IS2678B (de)
NO (1) NO331253B1 (de)
PL (1) PL197462B1 (de)
PT (1) PT1154757E (de)
RU (1) RU2242968C2 (de)
TR (1) TR200102504T2 (de)
WO (1) WO2000044351A1 (de)
ZA (1) ZA200105930B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9904049D0 (en) * 1999-02-22 1999-04-14 Quadrant Holdings Cambridge Rapidly-soluble compositions
US7550156B2 (en) * 2001-11-23 2009-06-23 Rohm And Haas Company Optimised pellet formulations
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
NZ535861A (en) * 2002-05-07 2006-11-30 Ferring Bv Desmopressin acetate in an orodispersible dosage form that disintegrates in the mouth within 10 seconds
DE10237459A1 (de) * 2002-08-16 2004-02-26 Beiersdorf Ag Wirkstoffhaltige kosmetische Zubereitung
UA93479C2 (en) * 2002-11-26 2011-02-25 Альк-Абелло A/C Allergen dosage form
AU2003280324A1 (en) * 2002-11-26 2004-06-18 Alk-Abello A/S Pharmaceutical allergen product
JP4688787B2 (ja) * 2003-02-28 2011-05-25 アルカベロ アクチェセルスカプ 糖類マトリックスを有する剤形
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
ITRM20030288A1 (it) * 2003-06-10 2004-12-11 Valerio Cioli Somministrazione sublinguale di antinfiammatori non steroidei (fans)
EP2322195A2 (de) 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmazeutische Zusammensetzungen mit niedrigen Dosen von Desmopressin
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
DE60305043T2 (de) 2003-11-13 2006-11-30 Ferring B.V. Blisterverpackung und feste Dosierungsform enthaltend Desmopressin
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
US20090155351A1 (en) 2005-10-04 2009-06-18 Alk-Abello A/S Solid Vaccine Formulation
CN101548958B (zh) * 2008-04-03 2012-10-17 万特制药(海南)有限公司 一种含有盐酸特比萘芬的分散片
ES2677548T3 (es) 2008-05-21 2018-08-03 Ferring B.V. Desmopresina bucodispersable para aumentar el periodo inicial de sueño ininterrumpido por nicturia
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
DE102008051579A1 (de) * 2008-10-14 2010-04-15 Rhodia Acetow Gmbh Biologisch abbaubarer Kunststoff und Verwendung desselben
EP2391355B1 (de) 2009-05-19 2017-01-18 Celgene Corporation Formulierungen von 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindolin-1,3-dion
RU2015144851A (ru) 2009-06-18 2019-01-10 Серенити Фармасьютикалз, Элэлси Безопасное применение десмопрессина
CN107811980B (zh) 2009-10-30 2021-06-18 Ix 生物医药有限公司 快速溶解固体剂型
US10548839B2 (en) * 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
BR112012024464B1 (pt) * 2010-03-28 2021-08-03 Firmenich Sa Processo para preparar um produto seco por pulverização utilizando maltodextrina, goma xantana e derivados de amido, para melhorar a taxa de dissolução do ingrediente ativo
JO3112B1 (ar) 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
TWI498132B (zh) 2010-03-29 2015-09-01 Ferring Bv 快速溶解之藥學組成物（二）
DK3095441T3 (da) * 2010-10-08 2021-01-11 Scherer Technologies Llc R P Hurtigt opløsende doseringsform af en oral vaccine under anvendelse af stivelse
AU2012307530B2 (en) 2011-09-16 2016-12-08 Ferring B.V. A fast dissolving pharmaceutical composition
RU2497505C1 (ru) * 2012-11-07 2013-11-10 Максим Эдуардович Запольский Новая лекарственная композиция для лечения болевого синдрома при спазме гладкой мускулатуры
RU2503447C1 (ru) * 2012-11-20 2014-01-10 Максим Эдуардович Запольский Лекарственное средство в форме ородисперсной таблетки и способ получения лекарственного средства
EP2952200A1 (de) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen zur vorbeugenden Behandlung von Allergien
CN106259891A (zh) * 2015-05-28 2017-01-04 上海旺旺食品集团有限公司 一种益生菌口含片及其制备方法
RU2674765C2 (ru) * 2016-10-03 2018-12-13 Михаил Лукич Ткаченко Антигрибковая композиция эвтектического типа (варианты)
US11839604B2 (en) 2016-12-31 2023-12-12 Bioxcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
BR112020026672A2 (pt) 2018-06-27 2021-03-30 Bioxcel Therapeutics, Inc. Formulações de filme contendo dexmedetomidina e métodos para produzi-las
KR20220049526A (ko) 2019-07-19 2022-04-21 바이오엑셀 테라퓨틱스 인코포레이티드 비-진정성 덱스메데토미딘 치료 양생법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
NL8304133A (nl) * 1983-12-01 1985-07-01 Unilever Nv Water-in-olie emulsies die gehydrateerde zetmeelkorrels bevatten.
DE4018247A1 (de) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
US5631023A (en) * 1993-07-09 1997-05-20 R.P. Scherer Corporation Method for making freeze dried drug dosage forms
GB9401892D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
AU713462B2 (en) * 1996-07-12 1999-12-02 Daiichi Pharmaceutical Co., Ltd. Quickly disintegrable compression-molded materials and process for producing the same
JP4292588B2 (ja) * 1997-01-31 2009-07-08 日産化学工業株式会社 ピリダジノン化合物類の経口製剤

Also Published As

Publication number Publication date
HK1037536A1 (en) 2002-02-15
BG65413B1 (bg) 2008-07-31
IL144412A0 (en) 2002-12-01
CN1193740C (zh) 2005-03-23
IL144412A (en) 2006-06-11
EP1154757B1 (de) 2008-01-02
EP1154757A4 (de) 2004-01-21
CY1107384T1 (el) 2012-01-25
NO331253B1 (no) 2011-11-07
IS6023A (is) 2001-07-25
ATE382334T1 (de) 2008-01-15
CZ20012700A3 (cs) 2002-08-14
AU768121B2 (en) 2003-12-04
HUP0105107A3 (en) 2006-07-28
CZ301249B6 (cs) 2009-12-23
PL197462B1 (pl) 2008-04-30
HUP0105107A2 (en) 2002-06-29
ZA200105930B (en) 2002-10-18
TR200102504T2 (tr) 2002-08-21
BG105739A (en) 2002-06-28
AU2972900A (en) 2000-08-18
WO2000044351A1 (en) 2000-08-03
EP1154757A1 (de) 2001-11-21
ES2298129T3 (es) 2008-05-16
JP4863336B2 (ja) 2012-01-25
RU2242968C2 (ru) 2004-12-27
CA2360647C (en) 2005-08-02
CA2360647A1 (en) 2000-08-03
IS2678B (is) 2010-09-15
KR100852015B1 (ko) 2008-08-12
DK1154757T3 (da) 2008-05-13
NO20013679L (no) 2001-09-19
DE60037653T2 (de) 2008-10-30
JP2003529535A (ja) 2003-10-07
KR20010111565A (ko) 2001-12-19
NO20013679D0 (no) 2001-07-26
CN1337876A (zh) 2002-02-27
HU226557B1 (en) 2009-03-30
GB9901819D0 (en) 1999-03-17
PT1154757E (pt) 2008-03-17

Similar Documents

Publication Publication Date Title
DE60037653D1 (de) Gelatine-freie schell dispergierende dosisformen
HUP0000141A2 (hu) Eljárás legfeljebb 90 tömeg% gyógyhatású anyagot tartalmazó pelletek előállítására
BE901994A (fr) Comprimes de principes actifs pharmaceutiques a delitement rapide, stables au stockage.
EA200001125A1 (ru) Гелеобразные фармацевтические композиции
RU2004111596A (ru) Офтальмические композиции в форме депо для периокулярного или субконъюнктивального введения
ATE234634T1 (de) Feste pharmazeutische formulierungen enthaltend eine physische mischung aus sulphoalkylethercyclodextrin und einem therapeutischen wirkstoff
FI962111A (fi) Mikrokapseloidut 3-piperidinyyli-substituoidut 1,2-bentsisoksatsolit ja 1,2-bentsisotiatsolit
FI842528A0 (fi) Fasta farmaceutiska preparat fraon vilka frigoeringen av det aktiva aemnet sker laongsamt via reglerad yterosion.
EE03471B1 (et) Dopamiini agonisti sisaldav farmatseutiline kompositsioon, selle kasutamine ja valmistamismeetod, farmatseutiline produkt ja komplekt ning antatsiidi kasutamine
EA200700055A1 (ru) Препаративные формы пероральных лекарственных форм мемантина с немедленным высвобождением
BR9908371A (pt) Formulação preservante lìquida de amplo espectro, método para sua preparação, solução de iodopropargila estabilizada e processo para eliminar ou retardar o crescimento de micróbios
HUP0203121A2 (hu) Szubsztituált benzimidazolokat tartalmazó gyógyszerkészítmény és alkalmazása
HUP0204202A2 (hu) Ibuprofent tartalmazó hatóanyag-preparátum, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények
ATE444739T1 (de) Polymerzusammensetzung sowie diese enthaltende darreichungsformen
EA200700979A1 (ru) Пероральные твердые лекарственные формы, содержащие низкую дозу эстрадиола
ATE359248T1 (de) Rauch erzeugende zusammensetzung
TR199900584T2 (xx) Amino asit esteri i�eren azol mantar �nleyiciler.
FR2719771B1 (fr) Compositions pharmaceutiques contenant du gemfibrozil.
DK1216043T3 (da) Formulering med forsinket frigivelse indeholdende alfa-liponsyre-(derivater)
MY101266A (en) Pharmaceutical formulations
MXPA05012655A (es) Isomeros puros d-(17a)-13 -etil-17-hidroxi -18, 19-dinorpregn- 4-eno-20-ino -3-ona-3e -y ??3z- oxima, asi como el proceso para la sintesis de la mezcla de isomeros y los isomeros puros.
AR036323A1 (es) Formas de dosis de rapida dispersion, libres de gelatina
EA200100794A1 (ru) Фармацевтическая композиция, ее применение и способ получения

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: CATALENT PHARMA SOLUTIONS ,INC., SOMERSET, NJ, US